Archon Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Acadia Healthcare
ACHC
|
+$12.8M |
| 2 |
SRCL
Stericycle Inc
SRCL
|
+$12.3M |
| 3 |
Mitek Systems
MITK
|
+$10.9M |
| 4 |
Apyx Medical
APYX
|
+$6.89M |
| 5 |
OneSpan
OSPN
|
+$6.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVP
Avon Products, Inc.
AVP
|
+$36.9M |
| 2 |
PVTL
Pivotal Software, Inc.
PVTL
|
+$4.84M |
| 3 |
ZIXI
Zix Corporation
ZIXI
|
+$4.42M |
| 4 |
Agilysys
AGYS
|
+$4.36M |
| 5 |
Vericel Corp
VCEL
|
+$3.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.98% |
| 2 | Healthcare | 13.81% |
| 3 | Industrials | 5.3% |
| 4 | Financials | 2.17% |
| 5 | Consumer Staples | 1.02% |
Similar funds
Archon Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Archon Capital Management held 37 positions worth $545M, up 49% from $367M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Archon Capital Management deployed $158M of net new capital in Q2 2019, opening 10 new positions and adding to 13 existing holdings. Its largest new stake was Acadia Healthcare: 395,763 shares worth $13.8M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Zix Corporation, an estimated $4.42M trimmed.
- Archon Capital Management's largest Q2 2019 buy was Acadia Healthcare: 395,763 shares worth $13.8M.
- Archon Capital Management added most to Stericycle Inc in Q2 2019, an estimated $12.3M increase.
- Archon Capital Management's biggest Q2 2019 reduction was Zix Corporation, cutting an estimated $4.42M.
- Archon Capital Management fully exited Avon Products, Inc. in Q2 2019, selling an estimated $36.9M.
- Archon Capital Management's ten largest holdings make up 79% of its $545M portfolio in Q2 2019.
- Archon Capital Management opened 10 new positions and closed 7 in Q2 2019.
- Archon Capital Management's portfolio value rose 49% quarter-over-quarter to $545M.
Based on Archon Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.